Xuerong Bio-Tech adjusts capital, governance; guarantees subsidiary loan

Shanghai Xuerong Bio-Technology Co., Ltd. held its Fifth Board of Directors' Thirty-First Meeting and Fifth Board of Supervisors' Eighteenth Meeting on August 26, 2025. The meetings approved amendments to its Articles of Association and various internal control systems.

These changes include an increase in the company's registered capital to 597,674,635 yuan due to the conversion of "Xuerong Convertible Bonds." The Articles of Association have been updated to reflect the new registered capital and to comply with regulations regarding director responsibilities and shareholder rights.

The Board also approved a proposal to provide a counter-guarantee for its wholly-owned subsidiary, Chengdu Xueguo Gaorong Biotechnology Co., Ltd. Chengdu Xueguo Gaorong plans to apply for comprehensive credit of up to 5 million yuan from Chengdu Rural Commercial Bank, Dujiangyan Branch. Shanghai Xuerong Bio-Technology will provide a joint and several liability counter-guarantee for this credit.

Additionally, the company published a notice for its Third Extraordinary General Meeting of 2025, scheduled for September 17, 2025. Shareholders will vote on the registered capital change, revised internal control systems (including those for shareholder meetings, board of directors, and independent directors), and the subsidiary counter-guarantee. The total amount of approved external guarantees by the company and its subsidiaries is 323,120.96 yuan (including 67,000 million baht).